Catamount Wealth Management’s Clorox CLX Stock Holding History

Catamount Wealth Management’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-170	Closed	-$23K	–	178
2017 Q1	$23K	Buy	+170	New	+$22K	0.02%	109

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VAM

ValueInvest Asset Management Luxembourg $1.47B AUM 0.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Catamount Wealth Management's CLX Position: Q2 2017 in Review

Catamount Wealth Management sold out of Clorox (CLX) in Q2 2017, closing a stake of 170 shares — an estimated $23K sold.

Catamount Wealth Management first reported a position in CLX in Q1 2017 and held it in 1 quarter. The position peaked at $23K in Q1 2017. 866 funds tracked by Wall St. Rank hold CLX as of Q2 2017.

Catamount Wealth Management reported no remaining Clorox position as of Q2 2017 after selling out during the quarter.
Catamount Wealth Management sold 170 Clorox shares in Q2 2017, an estimated $23K.
Catamount Wealth Management first reported a position in Clorox in Q1 2017 and held it in 1 quarter.
Catamount Wealth Management's Clorox position peaked at $23K in Q1 2017.
866 funds tracked by Wall St. Rank held Clorox as of Q2 2017.

Based on Catamount Wealth Management's 13F filing for Q2 2017, filed 4 Aug 2017.